Consensus Report
Berberine
Moderate Consensus
out of 5
Based on 12 videos (14 hours analyzed) across 5 experts · Updated 2026-03-19
Expert Positions
The Verdict
Berberine is a polarizing supplement among the 5 experts. Attia uses it clinically for LDL management in select patients but prefers metformin for glucose control. Huberman mentions it as a glucose disposal agent but personally avoids it for longevity. Hyman views it positively as an AMPK activator and gut antimicrobial. Patrick and Johnson have no direct coverage.
Where They Disagree
Huberman personally avoids berberine for longevity, citing insufficient human evidence, while Hyman frames it as a useful AMPK-activating anti-aging compound.
Attia prefers pharmaceutical-grade metformin over berberine for blood sugar management, viewing berberine as a 'weak' AMPK activator — while Hyman groups berberine with other longevity compounds as a direct tool for metabolic optimization.
+ 2 more disagreements in the full report
About This Analysis
This consensus report on Berberine is based on 12 videos (14 hours analyzed) from five longevity experts: Andrew Huberman, Peter Attia, Rhonda Patrick, Bryan Johnson, and Mark Hyman. Each expert's position was independently analyzed from their published video content, including lectures, podcast episodes, and Q&A sessions with 1,000+ guest scientists.
The full report includes 8 key findings, dosage and protocol details, expert deep dives with direct video citations and timestamps, risk considerations, and related supplement synergies.
Unlock the Full Report
Get dosages, timing protocols, expert deep dives with video citations, and risks for Berberine.
Every recommendation traces back to a specific expert, video, and timestamp.
$9/month or $79/year · Cancel anytime